Compare Agilent Technologies Inc (A) vs iShares MSCI United Kingdom (FTSE) (EWU) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Agilent Technologies Inc vs iShares MSCI United Kingdom (FTSE) — how do they compare? Agilent Technologies Inc trades at $129.06 (market cap $37.04B), while iShares MSCI United Kingdom (FTSE) trades at $46.44. The key difference: Agilent Technologies Inc pays a 0.78% dividend while iShares MSCI United Kingdom (FTSE) pays none, and iShares MSCI United Kingdom (FTSE) is trading nearer its 52-week high, Agilent Technologies Inc nearer its low. Which is the better fit depends on your goals.
| A | EWU | |
|---|---|---|
Market Cap | $37.04B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $157.20 | $48.68 |
52-Week Low | $110.24 | $39.59 |
Enterprise Value | $38.59B | — |
Dividend Yield | 0.78% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
EWU trades at $47.22, showing slight daily gains with a bullish technical outlook supported by moving averages. The ETF reflects UK market exposure, with recent news highlighting political uncertainty and economic challenges. Technical indicators show mixed signals with RSI suggesting potential overbought conditions near-term.
The outlook remains cautious due to UK political instability and economic headwinds, though potential short-squeeze dynamics and record European equity performances offer upside. Key risks include sterling weakness and domestic policy shifts. Investors should weigh geopolitical factors against valuation discounts in UK assets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About iShares MSCI United Kingdom (FTSE)
EWU is a country-specific ETF that tracks the performance of the United Kingdom equity market. It provides exposure to large and mid-sized UK companies, with significant weightings in financials, energy, and healthcare, including Shell, AstraZeneca, and HSBC.
Read more on EWU →
